- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cancer therapeutic targeting using mutant–p53-specific siRNAs ; day:14 ; month:1 ; year:2019 ; pages:1-13
Oncogene ; (14.1.2019), 1-13
- Creator
-
Ubby, Ifeoma
Krueger, Christian
Rosato, Roberto
Qian, Wei
Chang, Jenny
Sabapathy, Kanaga
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-018-0652-y
- URN
-
urn:nbn:de:101:1-2019022000391285100766
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ubby, Ifeoma
- Krueger, Christian
- Rosato, Roberto
- Qian, Wei
- Chang, Jenny
- Sabapathy, Kanaga
- SpringerLink (Online service)
Other Objects (12)
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Therapeutic targeting of microRNAs in the tumor microenvironment
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Therapeutic targeting of microRNAs in the tumor microenvironment
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond